Article: Other News To Note.

o Agilent Technologies Inc., of Palo Alto, Calif., introduced the whole-genome microarray for mouse. The microarray is designed to benefit scientists conducting genome-wide gene-expression profiling research in oncology, cardiovascular biology, immunology and toxicology/toxicogenomics. The whole-mouse genome microarray represents all known mouse genes and related transcripts, the company said.

o Angiotech Pharmaceuticals Inc., of Vancouver, British Columbia, said enrollment began in a study of a coronary stent that uses its paclitaxel coating. Boston Scientific Corp., of Natick, Mass., began the ATLAS trial to test its new Liberte coronary stent as a platform for ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!